Stewart Craig occupies the position of Chief Technical Officer at ERYTech Pharma SA.

He is also Member of International Society for Cellular Therapy.

Dr. Craig previously held the position of Senior Vice President-Technical Operations at Sangamo Therapeutics, Inc., Chief Manufacturing Officer at Orchard Therapeutics Plc, Vice President-Operations & Development at Osiris Therapeutics, Inc., Chief Operating Officer of Xcyte Therapies, Inc., Chief Technology Officer & Vice President at Minaris Regenerative Medicine LLC, EVP-Manufacturing Operations & Regulatory Affairs at StemCells, Inc., Vice President-Product & Process Development at Systemix, Inc., Principal at Ligand UK Ltd., Member of International Society for Pharmaceutical Engineering and Member of The United States Pharmacopeia.

Stewart Craig received an undergraduate degree and a doctorate from Newcastle University.